Nicola Davis1, Bibiana C Mota1, Larissa Stead1, Emily O C Palmer1, Laura Lombardero2, Rafael Rodríguez-Puertas2, Vincenzo de Paola3, Samuel J Barnes1,4, Magdalena Sastre5. 1. Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, W12 0NN, UK. 2. Department of Pharmacology, University of the Basque Country (UPV/EHU), 48940, Leioa, Spain. 3. Institute of Clinical Sciences, Imperial College London, London, W12 0NN, UK. 4. Imperial College UK-Dementia Research Institute, Hammersmith Hospital, London, W12 0NN, UK. 5. Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, W12 0NN, UK. m.sastre@imperial.ac.uk.
Abstract
BACKGROUND: Astrocytes provide a vital support to neurons in normal and pathological conditions. In Alzheimer's disease (AD) brains, reactive astrocytes have been found surrounding amyloid plaques, forming an astrocytic scar. However, their role and potential mechanisms whereby they affect neuroinflammation, amyloid pathology, and synaptic density in AD remain unclear. METHODS: To explore the role of astrocytes on Aβ pathology and neuroinflammatory markers, we pharmacologically ablated them in organotypic brain culture slices (OBCSs) from 5XFAD mouse model of AD and wild-type (WT) littermates with the selective astrocytic toxin L-alpha-aminoadipate (L-AAA). To examine the effects on synaptic circuitry, we measured dendritic spine number and size in OBCSs from Thy-1-GFP transgenic mice incubated with synthetic Aβ42 or double transgenics Thy-1-GFP/5XFAD mice treated with LAAA or vehicle for 24 h. RESULTS: Treatment of OBCSs with L-AAA resulted in an increased expression of pro-inflammatory cytokine IL-6 in conditioned media of WTs and 5XFAD slices, associated with changes in microglia morphology but not in density. The profile of inflammatory markers following astrocytic loss was different in WT and transgenic cultures, showing reductions in inflammatory mediators produced in astrocytes only in WT sections. In addition, pharmacological ablation of astrocytes led to an increase in Aβ levels in homogenates of OBCS from 5XFAD mice compared with vehicle controls, with reduced enzymatic degradation of Aβ due to lower neprilysin and insulin-degrading enzyme (IDE) expression. Furthermore, OBSCs from wild-type mice treated with L-AAA and synthetic amyloid presented 56% higher levels of Aβ in culture media compared to sections treated with Aβ alone, concomitant with reduced expression of IDE in culture medium, suggesting that astrocytes contribute to Aβ clearance and degradation. Quantification of hippocampal dendritic spines revealed a reduction in their density following L-AAA treatment in all groups analyzed. In addition, pharmacological ablation of astrocytes resulted in a decrease in spine size in 5XFAD OBCSs but not in OBCSs from WT treated with synthetic Aβ compared to vehicle control. CONCLUSIONS: Astrocytes play a protective role in AD by aiding Aβ clearance and supporting synaptic plasticity.
BACKGROUND: Astrocytes provide a vital support to neurons in normal and pathological conditions. In Alzheimer's disease (AD) brains, reactive astrocytes have been found surrounding amyloid plaques, forming an astrocytic scar. However, their role and potential mechanisms whereby they affect neuroinflammation, amyloid pathology, and synaptic density in AD remain unclear. METHODS: To explore the role of astrocytes on Aβ pathology and neuroinflammatory markers, we pharmacologically ablated them in organotypic brain culture slices (OBCSs) from 5XFAD mouse model of AD and wild-type (WT) littermates with the selective astrocytic toxin L-alpha-aminoadipate (L-AAA). To examine the effects on synaptic circuitry, we measured dendritic spine number and size in OBCSs from Thy-1-GFP transgenic mice incubated with synthetic Aβ42 or double transgenics Thy-1-GFP/5XFAD mice treated with LAAA or vehicle for 24 h. RESULTS: Treatment of OBCSs with L-AAA resulted in an increased expression of pro-inflammatory cytokine IL-6 in conditioned media of WTs and 5XFAD slices, associated with changes in microglia morphology but not in density. The profile of inflammatory markers following astrocytic loss was different in WT and transgenic cultures, showing reductions in inflammatory mediators produced in astrocytes only in WT sections. In addition, pharmacological ablation of astrocytes led to an increase in Aβ levels in homogenates of OBCS from 5XFAD mice compared with vehicle controls, with reduced enzymatic degradation of Aβ due to lower neprilysin and insulin-degrading enzyme (IDE) expression. Furthermore, OBSCs from wild-type mice treated with L-AAA and synthetic amyloid presented 56% higher levels of Aβ in culture media compared to sections treated with Aβ alone, concomitant with reduced expression of IDE in culture medium, suggesting that astrocytes contribute to Aβ clearance and degradation. Quantification of hippocampal dendritic spines revealed a reduction in their density following L-AAA treatment in all groups analyzed. In addition, pharmacological ablation of astrocytes resulted in a decrease in spine size in 5XFAD OBCSs but not in OBCSs from WT treated with synthetic Aβ compared to vehicle control. CONCLUSIONS: Astrocytes play a protective role in AD by aiding Aβ clearance and supporting synaptic plasticity.
Authors: Tony Wyss-Coray; John D Loike; Thomas C Brionne; Emily Lu; Roman Anankov; Fengrong Yan; Samuel C Silverstein; Jens Husemann Journal: Nat Med Date: 2003-03-03 Impact factor: 53.440
Authors: Hansruedi Mathys; Jose Davila-Velderrain; Zhuyu Peng; Fan Gao; Shahin Mohammadi; Jennie Z Young; Madhvi Menon; Liang He; Fatema Abdurrob; Xueqiao Jiang; Anthony J Martorell; Richard M Ransohoff; Brian P Hafler; David A Bennett; Manolis Kellis; Li-Huei Tsai Journal: Nature Date: 2019-05-01 Impact factor: 49.962
Authors: P Carriba; S Jimenez; V Navarro; I Moreno-Gonzalez; B Barneda-Zahonero; R S Moubarak; J Lopez-Soriano; A Gutierrez; J Vitorica; J X Comella Journal: Cell Death Dis Date: 2015-02-12 Impact factor: 8.469
Authors: Matylda Barbara Mielcarska; Katarzyna Skowrońska; Zbigniew Wyżewski; Felix Ngosa Toka Journal: Int J Mol Sci Date: 2021-12-27 Impact factor: 5.923
Authors: David S Bouvier; Sonja Fixemer; Tony Heurtaux; Félicia Jeannelle; Katrin B M Frauenknecht; Michel Mittelbronn Journal: Front Physiol Date: 2022-03-17 Impact factor: 4.566